Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Itopride improves gastric emptying in diabetic patients with gastroparesis

Oct. 3, 2005

Improved barrier function found with lubiprostone in ischemia-injured intestine

Oct. 3, 2005

AVI BioPharma begins HCV study for AVI-4065

Sep. 30, 2005

Proof-of-concept study for DDP-733 in constipation-predominant IBS

Sep. 30, 2005

Antiviral effects reported for celgosivir in patients with chronic hepatitis C

Sep. 30, 2005

AT-1001 enters phase I testing for celiac disease

Sep. 29, 2005

Actilon begins phase Ib study for chronic HCV

Sep. 29, 2005

IFN-alpha-XL shows promise in the management of chronic hepatitis C

Sep. 29, 2005

New therapeutic agents for gastrointestinal disorders revealed

Sep. 28, 2005

MicroRNA --a compelling target for anti-HCV therapy

Sep. 27, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...